These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16481735)

  • 1. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
    Hess AR; Seftor EA; Gruman LM; Kinch MS; Seftor RE; Hendrix MJ
    Cancer Biol Ther; 2006 Feb; 5(2):228-33. PubMed ID: 16481735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
    Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
    Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
    Yeo C; Lee HJ; Lee EO
    Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VE-cadherin fusion protein substrate enhanced the vasculogenic mimicry capability of hepatocellular carcinoma cells.
    Shuai Q; Cao L; Qin Z; Zhang Y; Gu Z; Yang J
    J Mater Chem B; 2020 Feb; 8(8):1699-1712. PubMed ID: 32016269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasculogenic mimicry--potential target for tumor therapy].
    Yue WY; Chen ZP
    Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
    Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
    Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
    Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
    Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    Yeo C; Han DS; Lee HJ; Lee EO
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular plasticity of human melanoma cells.
    Hendrix MJ; Seftor EA; Hess AR; Seftor RE
    Oncogene; 2003 May; 22(20):3070-5. PubMed ID: 12789282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
    Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.
    Hendrix MJ; Seftor EA; Meltzer PS; Gardner LM; Hess AR; Kirschmann DA; Schatteman GC; Seftor RE
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8018-23. PubMed ID: 11416160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.
    Zhao N; Sun BC; Sun T; Ma YM; Zhao XL; Liu ZY; Dong XY; Che N; Mo J; Gu Q
    Med Oncol; 2012 Dec; 29(5):3599-607. PubMed ID: 22562824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.
    Delgado-Bellido D; Serrano-Saenz S; Fernández-Cortés M; Oliver FJ
    Mol Cancer; 2017 Mar; 16(1):65. PubMed ID: 28320399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
    Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ
    Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
    Straume O; Akslen LA
    Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
    Hess AR; Seftor EA; Seftor RE; Hendrix MJ
    Cancer Res; 2003 Aug; 63(16):4757-62. PubMed ID: 12941789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.
    Liu R; Cao Z; Tu J; Pan Y; Shang B; Zhang G; Bao M; Zhang S; Yang P; Zhou Q
    Pigment Cell Melanoma Res; 2012 Sep; 25(5):630-8. PubMed ID: 22781316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
    Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.